SB 242084 monohydrochloride

SB 242084 monohydrochloride is a selective, competitive, and high-affinity 5-HT2C receptor antagonist (pKi=9.0) that can cross the blood-brain barrier. This compound enhances the basal activity of dopaminergic neurons in the ventral tegmental area (VTA) and increases dopamine release in the nucleus accumbens. Additionally, SB 242084 monohydrochloride boosts the expression of mitochondrial genes and oxidative metabolism via the 5-HT2A receptor. Its potential for research in anxiety, depression, negative symptoms of schizophrenia, and acute organ damage is significant.